乳腺肿块通过B超引导Mammotome微创旋切技术治疗现状

The Status of Mammotome Minimally Invasive Technique Guided by B Ultrasound in the Treatment of Breast Tumor

2004年美国FDA批准Mammotome真空辅助旋切活检系统用于乳腺良性肿块的微创切除,通过B超引导Mammotome微创旋切技术,可显著减少乳腺组织的损伤,尤其其具有成熟、安全、准确、创伤小等优点,仅一个进针点就能切除多个肿块,基本无瘢痕,与传统切除手术对比,有较多的优点,此项技术深受患者欢迎。

In 2004 the United States FDA approved Mammotome vacuum-assisted biopsy system for minimally invasive breast benign tumor resection, by B ultrasound guided Mammotome minimally invasive technique can significantly reduce breast tissue damage, especially it has the advantage of mature, safe, accurate, small trauma, only one point of the needle can remove multiple mass, no scar.With the traditional operation resection of contrast, have many advantages, this technology is welcomed by patients.